Trial intelligence / Profile preview

Dexamethasone for Post-thyroidectomy Hypocalcaemia and Voice Dysfunction

NCT04752852Completed

Sponsor
Holy Family Hospital
Start
Jan 2014
Primary completion
Dec 2019
Modality
Orthosteric Ligands
01

Overview

Randomised, double-blind trial in hypocalcemia and vocal cord dysfunction (VCD) comparing Dexamethasone with Placebo (2 arms). Primary endpoints: Hypocalcaemia at 3 days and Voice dysfunction at 24 hours. Started Jan 2014; status: completed.

02

Drugs

dexamethasone
03

Conditions

hypocalcemiavocal cord dysfunction (VCD)

Beyond the preview

Go deeper on NCT04752852.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04752852.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call